Area of research
Hepatology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Gallbladder and Bile Duct Disorders, Liver Disease and Transplantation, and Cholangiocarcinoma and Gallbladder Cancer Studies.
Prediction of treatment response and outcome of transarterial chemoembolization in patients with hepatocellular carcinoma using artificial intelligence: A systematic review of efficacy
New frontiers in radioembolization
Outcomes of repeat conventional transarterial chemoembolization in patients with liver metastases
Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI
Image-Guided Percutaneous Ablation for Primary and Metastatic Tumors
Percutaneous Image-guided Cryoneurolysis: Applications and Techniques
Intraarterial Therapies for the Management of Hepatocellular Carcinoma
Analysis of Tumor Burden as a Biomarker for Patient Survival with Neuroendocrine Tumor Liver Metastases Undergoing Intra-Arterial Therapies: A Single-Center Retrospective Analysis
Conventional vs. Drug-Eluting Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma—A Propensity Score Weighted Comparison of Efficacy and Safety
Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: Post-hoc analysis of a prospective clinical trial
Role of Resin Microsphere Y90 Dosimetry in Predicting Objective Tumor Response, Survival and Treatment Related Toxicity in Surgically Unresectable Colorectal Liver Metastasis: A Retrospective Single Institution Study
Lipiodol Deposition and Washout in Primary and Metastatic Liver Tumors After Chemoembolization
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE
Lipiodol as an Imaging Biomarker of Tumor Response After Conventional Transarterial Chemoembolization: Prospective Clinical Validation in Patients with Primary and Secondary Liver Cancer
Contemporary Management of Hepatic Trauma: What IRs Need to Know
Quantitative Imaging Biomarkers for<sup>90</sup>Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization
MR Imaging Measures of Intracranial Atherosclerosis in a Population-based Study